StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) stock

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.02 (-6.12%)

Close on Nov 17, 2026Market cap $6.04MP/E –Yield –

Actuate Therapeutics cash

Cash and short-term investments held at the end of each period.

Actuate Therapeutics's cash was $2.10M at Sep 30, 2026. For fiscal 2025 it was $13.16M, up 52.3% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.16M+52.3%
FY2024Dec 31, 2024$8.64M+192.1%
FY2023Dec 31, 2023$2.96M-85.5%
FY2022Dec 31, 2022$20.45M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.10M-87.6%
Q2 FY2026Jun 30, 2026$4.43M-31.8%
Q1 FY2026Mar 31, 2026$8.13M+109.1%
Q4 FY2025Dec 31, 2025$13.16M+52.3%
Q3 FY2025Sep 30, 2025$16.92M+25.2%
Q2 FY2025Jun 30, 2025$6.49M+1746.0%
Q1 FY2025Mar 31, 2025$3.89M+88.0%
Q4 FY2024Dec 31, 2024$8.64M+192.1%
Q3 FY2024Sep 30, 2024$13.52M+59.7%
Q2 FY2024Jun 30, 2024$351.71K-97.5%
Q1 FY2024Mar 31, 2024$2.07M-89.9%
Q4 FY2023Dec 31, 2023$2.96M–
Q3 FY2023Sep 30, 2023$8.47M–
Q2 FY2023Jun 30, 2023$14.11M–
Q4 FY2022Dec 31, 2022$20.45M–

More Actuate Therapeutics figures

See a number that looks wrong?